Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minesh Mehta

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023Robert Cardinale, Minhee Won, Ali Choucair, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2007
Breathing-synchronized delivery: a potential four-dimensional tomotherapy treatment techniqueTiezhi Zhang, Weiguo Lu, Gustavo H Olivera, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology GroupArnab Chakravarti, Wendy Seiferheld, Xiaoyu Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119)Lawrence Berk, Brian Berkey, Tyvin Rich, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2008
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402Caterina Giannini, Peter C Burger, Brian A Berkey, et al.
Surgical Neurology International|May 7, 2013
Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsyRohan R Lall, Stephen F Shafizadeh, Kyung-Hwa Lee, et al.
Neuro-Oncology|December 9, 2023
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001Hua-Ren R Cherng, Kai Sun, Søren Bentzen, et al.
Journal of Neuro-Oncology|May 17, 2017
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomasPriya Kumthekar, Sean Grimm, James Chandler, et al.
JTO Clinical and Research Reports|September 27, 2023
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian PopulationsJohn M Varlotto, Cristina Bosetti, Dwight Bronson, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023Robert Cardinale, Minhee Won, Ali Choucair, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2007
Breathing-synchronized delivery: a potential four-dimensional tomotherapy treatment techniqueTiezhi Zhang, Weiguo Lu, Gustavo H Olivera, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology GroupArnab Chakravarti, Wendy Seiferheld, Xiaoyu Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394Stuart A Grossman, Anne O'Neill, Margaret Grunnet, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119)Lawrence Berk, Brian Berkey, Tyvin Rich, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2008
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402Caterina Giannini, Peter C Burger, Brian A Berkey, et al.
Surgical Neurology International|May 7, 2013
Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsyRohan R Lall, Stephen F Shafizadeh, Kyung-Hwa Lee, et al.
Neuro-Oncology|December 9, 2023
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001Hua-Ren R Cherng, Kai Sun, Søren Bentzen, et al.
Journal of Neuro-Oncology|May 17, 2017
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomasPriya Kumthekar, Sean Grimm, James Chandler, et al.
JTO Clinical and Research Reports|September 27, 2023
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian PopulationsJohn M Varlotto, Cristina Bosetti, Dwight Bronson, et al.
Pageof 16